| Gut microbiota in health and disease I Sekirov, SL Russell, LCM Antunes, BB Finlay Physiological reviews, 2010 | 5167 | 2010 |
| Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine II Ivanov, R de Llanos Frutos, N Manel, K Yoshinaga, DB Rifkin, RB Sartor, ... Cell host & microbe 4 (4), 337-349, 2008 | 2075 | 2008 |
| Common themes in microbial pathogenicity revisited BB Finlay, S Falkow Microbiology and molecular biology reviews 61 (2), 136-169, 1997 | 1965 | 1997 |
| Recent advances in understanding enteric pathogenic Escherichia coli MA Croxen, RJ Law, R Scholz, KM Keeney, M Wlodarska, BB Finlay Clinical microbiology reviews 26 (4), 822-880, 2013 | 1903 | 2013 |
| Early infancy microbial and metabolic alterations affect risk of childhood asthma MC Arrieta, LT Stiemsma, PA Dimitriu, L Thorson, S Russell, ... Science translational medicine 7 (307), 307ra152-307ra152, 2015 | 1748 | 2015 |
| Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae C Lupp, ML Robertson, ME Wickham, I Sekirov, OL Champion, ... Cell host & microbe 2 (2), 119-129, 2007 | 1610 | 2007 |
| Molecular mechanisms of Escherichia coli pathogenicity MA Croxen, BB Finlay Nature Reviews Microbiology 8 (1), 26-38, 2010 | 1598 | 2010 |
| Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells B Kenny, R DeVinney, M Stein, DJ Reinscheid, EA Frey, BB Finlay Cell 91 (4), 511-520, 1997 | 1477 | 1997 |
| Anti-immunology: evasion of the host immune system by bacterial and viral pathogens BB Finlay, G McFadden Cell 124 (4), 767-782, 2006 | 1088 | 2006 |
| Salmonella, the host and disease: a brief review B Coburn, GA Grassl, BB Finlay Immunology and cell biology 85 (2), 112-118, 2007 | 1085 | 2007 |
| Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications F Bäckhed, CM Fraser, Y Ringel, ME Sanders, RB Sartor, PM Sherman, ... Cell host & microbe 12 (5), 611-622, 2012 | 1042 | 2012 |
| Common themes in microbial pathogenicity BB Finlay, S Falkow Microbiological reviews 53 (2), 210-230, 1989 | 1037 | 1989 |
| Exploitation of mammalian host cell functions by bacterial pathogens BB Finlay, P Cossart Science 276 (5313), 718-725, 1997 | 1000 | 1997 |
| Soluble CD14 participates in the response of cells to lipopolysaccharide. EA Frey, DS Miller, TG Jahr, A Sundan, V Bazil, T Espevik, BB Finlay, ... The Journal of experimental medicine 176 (6), 1665-1671, 1992 | 891 | 1992 |
| Shifting the balance: antibiotic effects on host–microbiota mutualism BP Willing, SL Russell, BB Finlay Nature Reviews Microbiology 9 (4), 233-243, 2011 | 872 | 2011 |
| Type III secretion systems and disease B Coburn, I Sekirov, BB Finlay Clinical microbiology reviews 20 (4), 535-549, 2007 | 827 | 2007 |
| Towards standards for human fecal sample processing in metagenomic studies PI Costea, G Zeller, S Sunagawa, E Pelletier, A Alberti, F Levenez, ... Nature biotechnology 35 (11), 1069-1076, 2017 | 794 | 2017 |
| Dissecting virulence: systematic and functional analyses of a pathogenicity island W Deng, JL Puente, S Gruenheid, Y Li, BA Vallance, A Vázquez, J Barba, ... Proceedings of the National Academy of Sciences 101 (10), 3597-3602, 2004 | 756 | 2004 |
| NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion M Wlodarska, CA Thaiss, R Nowarski, J Henao-Mejia, JP Zhang, ... Cell 156 (5), 1045-1059, 2014 | 737 | 2014 |
| The human microbiome and child growth–first 1000 days and beyond RC Robertson, AR Manges, BB Finlay, AJ Prendergast Trends in microbiology 27 (2), 131-147, 2019 | 710 | 2019 |
